Skip to content
Lower risk Medical device recall · FDA · Published July 30, 2025

Clearview Strep A Exact II Dipstick Respiratory Kit Recall: License Classification Error

Mckesson Medical-Surgical recalls Clearview Strep A Exact II Dipstick Respiratory Kit (Catalog 4581225020) due to shipping devices without proper license classification. All units are affected.

🇺🇸 FDA recall #Z-2337-2025Medical deviceMckesson Medical-Surgical ›
Take action

Contact the company

Recalling firmMckesson Medical-Surgical Inc. Corporate Office9954 Maryland Drive, Deep Run Iii Ste. 4000 · Richmond, VA 23233
✎ GovInfoNow plain-language explainer

Mckesson Medical-Surgical is recalling Clearview Strep A Exact II Dipstick Respiratory Kits because they were shipped without the correct license classification. This means healthcare providers may not legally use these kits as intended. Read more at govinfonow.com/recall/51714-clearview-strep-a-exact-ii-dipstick-respiratory-kit-recall-license.

Source Summary by GovInfoNow · govinfonow.com/recall/51714-clearview-strep-a-exact-ii-dipstick-respiratory-kit-recall-license · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2337-2025

Cite this page

“Clearview Strep A Exact II Dipstick Respiratory Kit Recall: License Classification Error.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/51714-clearview-strep-a-exact-ii-dipstick-respiratory-kit-recall-license. Based on FDA recall #Z-2337-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2337-2025%22&limit=1).

The FDA announced on July 30, 2025, that Mckesson Medical-Surgical Inc. Corporate Office is recalling Clearview Strep A Exact II Dipstick Respiratory Kits due to a classification error in the inventory management system. The hazard involves shipping devices to customers without the requisite license to purchase them.

How to tell if you have it

  • Brand: Mckesson Medical-Surgical
  • Product: Clearview Strep A Exact II Dipstick Respiratory Kit, CLIA Waived
  • Catalog Number: 4581225020
  • UPC: 10815845020024
  • Lot numbers: All lot numbers
  • Distribution: US Nationwide distribution in the state of Georgia

The hazard

According to the FDA, specific medical devices were shipped to customers that did not have the requisite license to purchase such devices due to a classification error in the inventory management system.

Context

GovInfoNow's records show Mckesson Medical-Surgical Inc. Corporate Office has 14 other recalls on record since June 2, 2021. Other recent recalls of similar products include Baxter Infuvite Adult Recall (April 25, 2025), Abbott Cholestech LDX Lipid Profile Glucose Test Kits (April 24, 2025), and EVENITY Injection Recall (April 21, 2025).

How to tell if you have this one

Check for the Catalog Number 4581225020 on the kit. All lot numbers are affected. The kit has GTIN 10815845020024.

  • Brand
    Mckesson Medical-Surgical
  • Product
    Clearview Strep A Exact II Dipstick Respiratory Kit, CLIA Waived. Catalog Number: 4581225020
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check License Status

    Verify if your healthcare facility has the proper license to use this kit before continuing use.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution in the state of Georgia.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 28 days after the firm started it.

1. Firm started the recall: Jul 30, 202512. FDA classified it Class II: Aug 18, 202523. Published in FDA’s Enforcement Report: Aug 27, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2337-2025 (July 30, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2337-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA